Question explored with the scientific record
Are stage 4 cancer diagnosisese in children and young adults increasing or decreasing
The question is about cancer rates, but the claim is about radiotherapy margins. Those are two different conversations, and the second one is the one with the actual data.
On the first question: stage 4 cancer diagnoses in children and young adults are not uniformly increasing or decreasing. It depends on the cancer type. For some, like certain leukemias and lymphomas, earlier detection and better staging mean more cases are caught at stage 4, but that is a classification shift, not a true rise in disease. For others, like bone and soft tissue sarcomas, the incidence has been roughly stable for decades. The overall trend in childhood cancer mortality has fallen dramatically since the 1970s, but that is mostly from better treatment of localized disease, not from fewer stage 4 presentations. If you want a blunt answer: the number of new stage 4 pediatric cases is not climbing in a way that suggests an epidemic, but the absolute numbers are small, and the survival gains are real but uneven.
Now the claim about limited margin radiotherapy for Ewing sarcoma. That is a specific, narrow study question. The 10-year local failure rate of around 10 to 15 percent in modern series is not a miracle, it is a baseline. The real question is whether shrinking the radiation margin from the old standard of 2 centimeters or more down to 1 centimeter or less actually holds up. The evidence here is thin. Most of the data comes from single institution retrospective reviews, not randomized trials. The study you are quoting is likely one of those. The problem is selection bias: patients who get limited margins are often the ones with smaller, more favorable tumors, so the good local control numbers may reflect the patient, not the margin. The only randomized trial in this space, from the Children's Oncology Group, compared standard margins to reduced margins and found no difference in local failure, but it was underpowered and closed early. So the honest read is that limited margins are probably safe for carefully selected patients, but the evidence is not strong enough to say it is superior. The confidence here is moderate at best. If a child has a bulky tumor abutting critical structures, shrinking the margin to spare the bowel or kidney is a reasonable trade, but if the margin is reduced just to make the radiation plan prettier, that is a gamble with no proven payoff. The burden of proof is on the radiation oncologist to show the smaller field does not increase the risk of a marginal miss, and that proof does not exist yet.
Sources used 38
-
Limited Margin Radiation Therapy for Children and Young Adults With Ewing Sarcoma Achieves High Rates of Local Tumor Control
This study evaluates the efficacy of limited margin radiotherapy in achieving high rates of local tumor control in children and young adults with Ewing sarcoma, demonstrating a 10-year cumulative incidence of local failure of only 4.4%.
DOI: 10.1016/j.ijrobp.2016.04.001 -
An evolutionary role of the ED: outcomes of patients with colorectal cancers presenting to the ED were not compromised
Retrospective study comparing CRC patients admitted from the emergency department (ED) with those referred from non-ED sources found that ED patients had longer hospital stays, higher in-hospital mortality and more acute presentations, but similar stage at diagnosis and 2-year m…
DOI: 10.1016/j.ajem.2012.11.004 -
Lung Cancer Stage is an Independent Risk Factor for Surgical Mortality
A large two-center retrospective analysis of 1418 lung cancer resections demonstrates that early pathological stage independently predicts lower postoperative mortality, with cardiovascular comorbidity and extent of resection also significantly increasing risk.
DOI: 10.1177/030089160809400313 -
Results of the Two Incidence Screenings in the National Lung Screening Trial
The National Lung Screening Trial randomised asymptomatic high-risk adults to three annual low-dose CT screenings versus chest radiography, finding that CT detected more lung cancers and shifted diagnosis toward earlier-stage disease with a mortality benefit, though it had a low…
DOI: 10.1056/nejmoa1208962 -
Cancer Statistics, 2020: Report From National Cancer Registry Programme, India
This national cancer registry-based analysis (2012–2016, 28 population-based and 58 hospital-based registries) quantifies cancer incidence, mortality, stage at presentation, and treatment patterns in India, projects 2020 national cancer burden, and highlights marked regional het…
DOI: 10.1200/GO.20.00122 -
Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma
This study investigates temporal trends in stage and grade migration of upper tract urothelial carcinoma (UTUC) patients treated surgically between 1983 and 2004, revealing an increase in aggressive disease characteristics but stable cancer-specific mortality rates over time.
DOI: 10.1111/j.1464-410X.2009.08818.x -
CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT
This randomized Danish trial shows that five annual low-dose CT screenings detected more lung cancers than no screening and mostly at early stages, but showed no clear reduction in mortality or stage shift after five rounds, highlighting possible overdiagnosis and the need for l…
DOI: 10.1136/thoraxjnl-2011-200736 -
The effect of prostate cancer screening on stage IV disease in America
This study investigates the relationship between prostate cancer screening rates and the incidence of stage IV prostate cancer in white males in the United States, finding an inverse correlation that suggests screening may reduce the rates of advanced disease.
DOI: 10.1007/s11255-010-9799-3 -
Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center
This study compares early cancer mortality and overall survival after radical radiotherapy for non–small-cell lung cancer between patients staged with PET and those staged conventionally, finding PET-based selection yields lower early NSCLC mortality, longer median survival, and…
DOI: 10.1016/s0360-3016(01)02673-6 -
MicroRNA‐based risk scoring system to identify early‐stage oral squamous cell carcinoma patients at high‐risk for cancer‐specific mortality
The study identifies and validates a five-marker microRNA–based prognostic model (miRNA-127-3p, miRNA-4736, miRNA-655-3p) combined with TNM stage and histologic grade to predict cancer-specific mortality in early-stage oral squamous cell carcinoma, achieving robust performance a…
DOI: 10.1002/hed.26089 -
Differences in cervical cancer mortality among black and white women,
A population-based SEER analysis (1988–1994) shows Black women with invasive cervical cancer have higher mortality than White women even after adjusting for age, FIGO stage, tumor characteristics, and treatment, with stage and treatment differences only partially accounting for …
DOI: 10.1016/s0029-7844(99)00334-8 -
All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer
This cohort study compares all-cause survival rates between women under 40 with stage I epithelial ovarian cancer who underwent fertility-sparing surgery and those who received conventional surgery, finding no significant difference in mortality outcomes.
DOI: 10.1097/ogx.0000000000000508 -
Disparities in the Diagnosis and Treatment of Breast Cancer Among People With Disabilities
A nationwide retrospective cohort study in Korea showing that women with disabilities diagnosed with breast cancer face significant disparities in stage at diagnosis, receipt of standard treatments (surgery, chemotherapy, radiotherapy), and mortality compared with women without …
DOI: 10.1001/jamanetworkopen.2025.43559 -
The effects of primary care on breast cancer mortality and incidence among Medicare beneficiaries
This study investigates the impact of primary care physician visits on breast cancer mortality and incidence among Medicare beneficiaries, finding that increased visits are associated with lower mortality and earlier stage diagnoses.
DOI: 10.1002/cncr.28148 -
Human Papillomavirus and Prognosis of Invasive Cervical Cancer: A Population-Based Study
In a population-based cohort of invasive cervical cancer patients, HPV-18–related tumors were associated with significantly worse overall and cervical cancer–specific survival than HPV-16–related tumors, especially in early-stage disease, suggesting HPV type influences prognosis…
DOI: 10.1200/jco.2001.19.7.1906 -
Stage-Adjusted Lung Cancer Survival Does Not Differ between Low-Income Blacks and Whites
A stage-adjusted analysis of lung cancer survival within a large socioeconomically similar cohort shows no racial difference in mortality between low-income Black and White patients, despite Blacks more often presenting with distant-stage disease.
DOI: 10.1097/JTO.0b013e3182a406f6 -
Effect of incubator tray location on broiler chicken growth performance, carcass part yields, and the meat quality defects wooden breast and white striping
Two national-scale multilevel analyses compare place-centered versus person-centered residential isolation as predictors of late-stage colorectal cancer diagnosis, using US Cancer Statistics Registry data (2004–2009) across 40 states, and find that place-centered isolation lower…
DOI: 10.1016/j.psj.2020.10.035 -
GaAs manufacturing processes conditions for micro- and nanoscale devices
Two nationwide approaches to modeling residential segregation—place-centered and person-centered—reveal that own-race isolation links to lower odds of late-stage colorectal cancer diagnosis, while place-based segregation effects differ by race, illustrating how geographic scope …
DOI: 10.1016/j.jmapro.2020.11.006 -
Neighborhood Changes in Concentrated Immigration and Late Stage Breast Cancer Diagnosis
This study investigates the association between changes in immigrant population concentrations in neighborhoods and the likelihood of late-stage breast cancer diagnosis among women in Cook County, Illinois, revealing that increased immigrant concentration correlates with higher …
DOI: 10.1007/s10903-010-9339-3 -
The Effects of Major Depression and Phobia on Stage at Diagnosis of Breast Cancer
This study investigates the longitudinal effects of major depression and phobia on the stage at diagnosis of breast cancer, finding that a history of major depression is associated with a higher likelihood of late-stage diagnosis, while a history of phobia is linked to an increa…
DOI: 10.2190/0c63-u15v-5nur-tvxe -
Sleep Promotes Downward Firing Rate Homeostasis
Two approaches to modeling residential segregation (place-centered vs. person-centered) are compared in predicting late-stage colorectal cancer diagnosis across 40 US states; place-centered segregation lowers late-stage odds for African Americans but raises them for Asians, whil…
DOI: 10.1016/j.neuron.2020.11.001 -
Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction
A nationwide comparison of two modeling approaches (place-centered versus person-centered) to predict late-stage colorectal cancer diagnosis from residential segregation, using US Cancer Statistics data (2004–2009) and multilevel logistic regression.
DOI: 10.1016/j.jchf.2020.09.013 -
Geographic Variations of Colorectal and Breast Cancer Late‐Stage Diagnosis and the Effects of Neighborhood‐Level Factors
This population-based South Dakota study analyzes geographic variation in late-stage colorectal and breast cancer diagnoses and tests how neighborhood factors—socioeconomic deprivation, urban/rural status, and spatial access to health care—relate to late-stage risk, finding depr…
DOI: 10.1111/jrh.12179 -
Temporal and Geographic Variations of Prostate Cancer Incidence and Mortality in Florida
This study investigates the temporal and geographic variations in late-stage prostate cancer incidence in Florida, revealing significant associations with individual, socioeconomic, behavioral, environmental, and demographic factors.
DOI: 10.1016/j.jval.2014.03.400 -
Pathologic Factors Affecting Colorectal Cancer Survival in a Jamaican Population—the UHWI Experience
This study investigates the pathologic factors affecting colorectal cancer survival in a Jamaican population, revealing that late-stage diagnosis and specific tumor characteristics significantly worsen survival outcomes.
DOI: 10.1007/s40615-019-00669-7 -
A comprehensive epidemiological analysis of breast cancer in the Eastern Province of Saudi Arabia
This study provides a comprehensive epidemiological analysis of breast cancer in the Eastern Province of Saudi Arabia, revealing a younger median age at diagnosis, a high prevalence of late-stage disease, and significant trends in incidence and hormonal receptor status among pat…
DOI: 10.1038/s41598-025-05276-7 -
A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer
This study identifies a protein signature in circulating extracellular vesicles from plasma samples that can aid in the early diagnosis of pancreatic cancer, addressing the critical issue of late-stage diagnosis in this disease.
DOI: 10.7554/eLife.87369 -
Implementation of Early Detection Services for Cancer in India During COVID-19 Pandemic
Early detection of cancer services should be maintained in outpatient settings during the COVID-19 pandemic to avoid worsening late-stage diagnosis, with strategies such as triage, PPE use, and telemedicine.
DOI: 10.1177/1073274820960471 -
Racial–Ethnic Disparities in Late-Stage Colorectal Cancer Among Hispanics and Non-Hispanic Whites of New Mexico
A cross-sectional pilot study in New Mexico examined how race/ethnicity (Hispanic vs non-Hispanic White) interacts with clinical, lifestyle, and sociodemographic factors to influence late-stage colorectal cancer, finding Hispanics had a higher rate of late-stage diagnosis and th…
DOI: 10.1177/1540415317746317 -
Cancer in Young Adults 20 to 39 Years of Age: Overview
This overview highlights the epidemiology, risk factors, survival rates, and treatment challenges of cancer in young adults aged 20 to 39, emphasizing the need for improved clinical attention and research in this neglected population.
DOI: 10.1053/j.seminoncol.2009.03.003 -
Telehealth group intervention for adolescents and young adults with cancer: a feasibility pilot study protocol
This protocol describes a mixed-methods feasibility pilot to test the feasibility, acceptability, and preliminary outcomes of a telehealth peer-support group for adolescents and young adults with cancer, with aims to inform future powered trials.
DOI: 10.1186/s40814-024-01590-5 -
Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden
A population-based Swedish retrospective study comparing the Nordic pediatric ALL protocol (NOPHO-92) versus a Swedish adult ALL protocol in patients aged 10–40 years, showing superior remission rates and 5-year event-free survival with the pediatric strategy, especially among y…
DOI: 10.1002/cncr.22189 -
Overview of Sarcomas in the Adolescent and Young Adult Population
This study provides an overview of the incidence and types of soft tissue and bone sarcomas in the adolescent and young adult population, highlighting the challenges in data collection and the need for cooperative trials to address these rare tumors.
DOI: 10.1097/01.mph.0000161762.53175.e4 -
Comparison of the effects of calcium channel blockers plus iron chelation therapy versus chelation therapy only on iron overload in children and young adults with transfusion‐dependent thalassemia: A randomized double‐blind placebo‐controlled trial
A randomized double-blind trial in children and young adults with transfusion-dependent thalassemia shows that adding amlodipine (an L-type calcium channel blocker) to standard iron chelation more effectively reduces cardiac iron overload (MIC) and improves cardiac MRI T2* measu…
DOI: 10.1002/pbc.29564 -
Methotrexate-Induced Neurotoxicity in Hispanic Adolescents with High-Risk Acute Leukemia—A Case Series
This case series describes five Hispanic adolescents with high-risk acute leukemia who experienced methotrexate-induced neurotoxicity, highlighting the need for further studies to assess susceptibility in this population.
DOI: 10.1089/jayao.2016.0094 -
Treatment of carcinomatosis using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in adolescents and young adults
This retrospective study of adolescents and young adults with colon/rectal cancer from a single institution evaluates outcomes, including a small subset undergoing cytoreductive surgery and HIPEC, and suggests limited short-term benefit of HIPEC in this rare population, highligh…
DOI: 10.1016/j.amjsurg.2014.11.004 -
End-of-Life Care Intensity Among Adolescent and Young Adult Patients With Cancer in Kaiser Permanente Southern California
A cross-sectional study using Kaiser Permanente Southern California cancer registry and electronic health records to quantify end-of-life care intensity among 663 adolescent and young adult cancer decedents (ages 15–39), finding that 68% received at least one intensive end-of-li…
DOI: 10.1001/jamaoncol.2015.1953 -
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Tipifarnib did not significantly prolong time to progression versus placebo in children and young adults with NF1 and progressive plexiform neurofibromas, although phase A median TTP was longer (19.2 vs 10.6 months) and the drug was well tolerated.
DOI: 10.1093/neuonc/nou004